Sort
38,696 grants matching “als”
Mobile DNA in Drug Abuse
$430,557Wade H Berrettini · University Of Pennsylvania · R01 · FY2018 · DA
Robust trans-synaptic labeling technologies for cell type-specific quantitation of synaptic connectivity
$430,477Edward M Callaway · University Of California, San Diego · U19 · FY2019 · MH
Efficient estimation of auditory sensitivity and cognitive status using spoken-digit tests.
$430,438Gary R Kidd · Communication Disorders Technology, Inc · R33 · FY2021 · DC
Glycogen promotes protein aggregation in ALS and FTD
$430,375Yongjie Zhang · Mayo Clinic Jacksonville · R21 · FY2022 · NS
Uncovering RNA signatures of C9ORF72-linked ALS and related disorders
$430,375Marka Van Blitterswijk · Mayo Clinic Jacksonville · R21 · FY2019 · NS
Mechanistic insights of cortical hyperexcitability in ALS
$430,375Jie Jiang · Emory University · R21 · FY2023 · NS
Mechanisms of altered RNA transport dynamics by Kif1C mutations in heterospastic paraplegia
$430,375Gary J Bassell · Emory University · R21 · FY2025 · NS
Investigating Toxic Elements and Nanoparticles in ALS Etiology: A Geospatial and Toxicological Evaluation of Massachusetts ALS Registry Patients
$430,310Elijah W Stommel · Dartmouth-Hitchcock Clinic · R01 · FY2022 · ES
NUP50 as a modifier and risk factor for TDP-43 pathology in FTD/ALS
$430,267Wilfried Rossoll · Mayo Clinic Jacksonville · R21 · FY2023 · AG
Identifying New Glioma-Associated Tumor Suppressors Oncogenes
$430,226Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Military exposures and ALS in a large veteran population
$430,197Marc G Weisskopf · Harvard School Of Public Health · R01 · FY2023 · TS
Military exposures and ALS in a large veteran population
$430,197Marc G Weisskopf · Harvard School Of Public Health · R01 · FY2022 · TS
Identification of vascular inductive signals in liver regeneration
$430,066Shahin Rafii · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · DK
Molecular Mechanisms and Treatment of Primary Amyloid (AL) Cardiomyopathy
$430,000Ronglih Liao · Brigham And Women'S Hospital · R01 · FY2011 · HL
Molecular Mechanisms and Treatment of Primary Amyloid (AL) Cardiomyopathy
$430,000Ronglih Liao · Brigham And Women'S Hospital · R01 · FY2009 · HL
Fluctuations of Amorphous Metals in Time and Space from Electron Nanodiffraction
$430,000Paul M Voyles · University Of Wisconsin-Madison · · FY2009 · MPS
NRI-Small: Collaborative Research: Assistive Robotics for Grasping and Manipulation using Novel Brain Computer Interfaces
$430,000Sanjay S Joshi · University Of California-Davis · · FY2012 · CSE
Molecular Mechanisms and Treatment of Primary Amyloid (AL) Cardiomyopathy
$430,000Ronglih Liao · Brigham And Women'S Hospital · R01 · FY2008 · HL
Molecular Mechanisms and Treatment of Primary Amyloid (AL) Cardiomyopathy
$430,000Ronglih Liao · Brigham And Women'S Hospital · R01 · FY2010 · HL
Molecular Mechanisms and Treatment of Primary Amyloid (AL) Cardiomyopathy
$430,000Ronglih Liao · Brigham And Women'S Hospital · R01 · FY2007 · HL
High-throughput Electrophysiology for Pathway Identification
$429,994James J Hickman · University Of Central Florida · R01 · FY2006 · EB
Developmental Nicotine Exposure & Transgenerationally Altered Lung Phenotype
$429,911Virender K Rehan · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2017 · HL
Structural and Microstructural Studies of Ti/Zr- and Al-Based Quasicrystal, Approximants and Metallic Glasses
$429,882Kenneth F Kelton · Washington University · · FY2000 · MPS
Project 2: The cohesin complex as a tumor suppressor in myeloid leukemia
$429,880Ari M. Melnick · New York University School Of Medicine · P01 · FY2019 · CA
Proteostasis in Aging and Neurodegenerative Disease
$429,778Richard I. Morimoto · Northwestern University · P01 · FY2020 · AG